Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Interview: Pieter Sonneveld
6
Mins
May 2026
I started to gain an interest in haematology during my medical studies, specifically why patients with leukaemia did so poorly on any…
Read more
6
Mins
11 May 2026
Interview: Pieter Sonneveld
I started to gain an interest in haematology during my medical studies, specifically why patients with leukaemia did so poorly on any…
15 Apr 2026
Entering a New Era in Protection in Haemophilia A
Haemophilia A (HA), defined by factor VIII (FVIII) levels ≤40 IU/dL, is a chronic condition with consequences beyond bleeding…
8
Mins
30 Mar 2026
Treating Autoimmune Cytopenias
The ‘Multi-immune modulation: a paradigm shift in understanding and treating immune thrombocytopenia (ITP) and warm autoimmune…
6
Mins
26 Feb 2026
ASH Interview: Robert Negrin
ASH Interview:Robert Negrin, Professor of Medicine, Stanford University, California, USA; President, American Society of Hematology (ASH)….
1
Mins
16 Dec 2025
Unwrap the Best of Hematology
It’s time for Unwrapped 2025. Explore Hematology’s defining moments, our Word of the Year, and a challenging brain teaser.
11
Mins
5 Dec 2025
Sponsored Content: Optimal Care of Unfit Patients with FTL3+ AML
This publication is intended for healthcare professionals only and has been commissioned and funded by Astellas Pharma Ltd.
26 Nov 2025
Recent Developments in Chronic Lymphocytic Leukaemia Research: Interview with an Expert
Explore the latest advancements in chronic lymphocytic leukaemia research and treatment with Talha Munir…
6
Mins
11 Sep 2025
Nivolumab in Patients with Relapsed-Refractory Hodgkin Lymphoma
Up to a quarter of patients with classical Hodgkin’s lymphoma (HL) are resistant or have disease relapse after first-line chemotherapy…
Loading posts...
1
2
3
…
25
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View